> Drug discovery is similar AFAIK. The space of possibilities is even larger than protein folding, but it's structurally similar enough that I think AI will help to make progress on the discovery side.

I do agree that this kind of targeted approach makes sense.

However, discovery is not really the issue here. Running the clinical trials (1/2/3) is much much more difficult, and consumes basically all of the time in drug development, so even if LLMs perfectly automate this, the speedup will not be particularly large.